Aaron McKinley is a writer, blogger and video game enthusiast with over five years of experience in web content and many more in playing games until the wee hours of the morning. His work spans many ...

The Counter-Strike 2 community has been thrown into turmoil after a fateful update from Valve sent shockwaves through Steam’s marketplace, causing the value of skins (purchased with real money) to ...

Counter-Strike 2’s October 23 update has sent shockwaves through the skin trading community, with the game’s total market cap dropping from a peak of around $6 billion to under $5 billion in the ...

Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall ...

Arsenal Women returned to form in the Champions League with a 2-0 win over Benfica, but the victory came at a cost as their injury list continues to grow. Emily Fox left the pitch after a heavy ...

KANSAS CITY, Mo. — T-shirts are being made after thousands of people attended a parade for a boy with a rare genetic disorder. A 3-year-old boy, Tucker Langord, was born with a rare genetic disorder ...

KSHB 41 reporter La’Nita Brooks covers stories providing solutions and offering discussions on topics of crime and violence. Share your story idea with La’Nita. Dozens of trucks, motorcycles and even ...

People with Sweet's syndrome often wake up with a fever, body aches, and blisters on their neck, limbs and face. Also known as acute febrile neutrophilic dermatosis, it is an inflammatory skin disease ...

When it comes to Call of Duty, everyone wants to frag out in style. Whether you’re sliding through a Warzone lobby or flexing in Modern Warfare III’s multiplayer, skins are the ultimate status symbol.

Overall response rates with immune checkpoint inhibitors were high in patients with pleomorphic dermal sarcoma and cutaneous angiosarcoma. The efficacy of systemic therapy varies among patients with ...

The FDA has approved a Novartis drug for chronic spontaneous urticaria (CSU), providing patients an oral treatment alternative to currently available injectable medications. The regulatory decision ...